Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @awmcconaghie
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @awmcconaghie
-
Regeneron latest to join coronavirus research effortshttps://scrip.pharmaintelligence.informa.com/articles/2020/02/05/coronavirus-notebook-regeneron-hhs-to-develop-antibody …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Andrew McConaghie proslijedio/la je Tweet
All rise: The new edition of Private Eye is out now.pic.twitter.com/wtPRroywNL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Andrew McConaghie proslijedio/la je Tweet
Brexit Finally Here But Uncertainty Not Over For Biopharma http://bit.ly/2RIWKuY
#PharmaScripHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Andrew McConaghie proslijedio/la je Tweet
Nigel Farage has just unveiled a portrait of himself entitled "Mr Brexit". Jim Davidson is now giving a speech to mark the occasion. Happy Brexit everyonepic.twitter.com/dCDnfqywwt
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
An interesting test case in the problems of using real world data in the, er, real world.https://scrip.pharmaintelligence.informa.com/articles/2020/01/24/after-realworld-data-row-az-looks-to-nhs-england-for-tagrisso-deal …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
UK
#biotech funding held up in 2019, despite Woodford and Brexit. Expect IPOs to stay thin on the ground in 2020. Speedy clinical progress still paramount for IO, gene and cell therapy start-upshttps://scrip.pharmaintelligence.informa.com/articles/2020/01/23/uk-biotech-financing-holds-up-despite-woodford-and-brexit …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Once an industry pariah thanks to price-gouging on old medicines, Horizon begins its reinvention with US approval of first treatment for thyroid eye diseasehttps://scrip.pharmaintelligence.informa.com/articles/2020/01/22/horizon-sees-blockbuster-future-for-tepezza-after-us-approval …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Andrew McConaghie proslijedio/la je Tweet
@LozzaFox Here's a pic of me and some friends reenacting the 15th Ludhiana Sikhs with@NAM_London. They were sent to the WESTERN Front and fought alongside British soldiers!#Sikhs and other commonwealth soldiers gave their lives for you to have your freedoms now.pic.twitter.com/UY69He0oht
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Andrew McConaghie proslijedio/la je Tweet
Two boys decide to prank their grandmother by meeting her at the airport dressed as dinosaurs. Grandma heard about it and decided to prank them first. Maybe the greatest prank ever! https://twitter.com/edstetzer/status/1216829740889194496/video/1 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Biopharma CEOs join debates on future of science, business and society - though whether they can influence US and Chinese leaders on healthcare policy is another matter https://scrip.pharmaintelligence.informa.com/articles/2020/01/21/biopharma-leaders-join-trump-and-thunberg-in-davos …
#Davos2020Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Vas Narasimhan gets biggest laugh in exchange with
@medicxi 's Francesco De Rubertis who asks 3 CEOs to name their next M&A targets. Vas jokes: I've a question for you: do you feel biotech evaluation expectations have got completely out of hand?!#JPMHC20pic.twitter.com/5uyVIo0udI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Andrew McConaghie proslijedio/la je Tweet
Good morning & welcome to
#JPM20 Day 2! Here’s a Day 1 recap from me,@Jessicaemerrill &@awmcconaghie available for free without a subscription to@PharmaScrip &@PharmaPinkSheet. Watch for more presentation and interview highlights in the coming days.https://scrip.pharmaintelligence.informa.com/SC141463/JP-Morgan-Notebook-Day-1-No-Big-Deals-But-Plenty-Of-Pipeline-Commercial-Highlights …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What a lovely way to warm up for
#JPM20, and what great company. Though we need to hire somebody from a fourth continent with long arms to take the selfie.@PharmaScrip@PharmaPinkSheethttps://twitter.com/Jessicaemerrill/status/1216602746234630145 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A great article by my colleague Brian Yang on the explosive growth in China biopharma, including first China-developed drugs gaining US approval. Lots of Chinese companies here at
#JPM20 and#ChinaShowcase in San Franciscohttps://scrip.pharmaintelligence.informa.com/articles/2020/01/07/10-commercial-trends-to-watch-in-china-in-2020 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The excellent
@PredatorDiaries on the annual ramping up of investor expectation ahead of#JPM20https://twitter.com/PredatorDiaries/status/1215279456102887427 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Alnylam's alliance with Regeneron could help it unlock the full potential of its RNAi tech - but Ionis has the lead in CNS therapies such as Huntington's https://scrip.pharmaintelligence.informa.com/articles/2020/01/08/alnylam-interview-rnai-leader-expands-into-nash-cns-and-eye-diseases …
$ALNY$IONS$REGNHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dicerna Ready To Challenge Alnylam’s RNAi Dominance In 2020https://scrip.pharmaintelligence.informa.com/articles/2020/01/05/dicerna-ready-to-challenge-alnylams-rnai-dominance-in-2020 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The year ahead almost certain to see more gene therapy companies snapped up. AbbVie and Takeda expected to extend their 2019 buying sprees into the new year. https://scrip.pharmaintelligence.informa.com/articles/2020/01/02/gene-therapy-companies-among-top-ma-targets-in-2020 …
#pharma#m&a#genetherapyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The 2010s: A Decade Of Acceleration, Innovation And Controversyhttps://scrip.pharmaintelligence.informa.com/articles/2019/12/31/the-2010s-a-decade-of-acceleration-innovation-and-controversy …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Andrew McConaghie proslijedio/la je Tweet
I think everyone at ITV, C4 and elsewhere should be very careful about feeling good about this. It may not be that we are doing anything different, nor that the BBC are doing anything different, but just that the attacks on us haven’t started yet.https://twitter.com/JohnMHardie/status/1210999178467463169 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.